Cargando…
Discovery of bladder cancer biomarkers in paired pre- and postoperative urine samples
BACKGROUND: Bladder cancer (BC), a common cancer of the urinary system, has a low mortality but an extremely high recurrence rate. Patients who have undergone initial surgical treatment often undergo frequent prognostic examinations with a substantial burden of discomfort and costs. Urine samples ca...
Autores principales: | Li, Xuechao, Huang, Chuanxi, Zhang, Xueli, Yang, Tao, Zuo, Shidong, Fu, Chengwei, Zhang, Yongjie, Yang, Chunyuan, Chen, Lijun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8421825/ https://www.ncbi.nlm.nih.gov/pubmed/34532265 http://dx.doi.org/10.21037/tau-21-562 |
Ejemplares similares
-
Bladder Cancer Biomarker Discovery Using Global Metabolomic Profiling of Urine
por: Wittmann, Bryan M., et al.
Publicado: (2014) -
Discovery of Volatile Biomarkers for Bladder Cancer Detection and Staging through Urine Metabolomics
por: Pinto, Joana, et al.
Publicado: (2021) -
Trends in urine biomarker discovery for urothelial bladder cancer: DNA, RNA, or protein?
por: Humayun-Zakaria, Nada, et al.
Publicado: (2021) -
Novel Metabolomics Serum Biomarkers for Pancreatic Ductal Adenocarcinoma by the Comparison of Pre-, Postoperative and Normal Samples
por: Zhang, Xiaohan, et al.
Publicado: (2020) -
Bladder cancer-related microbiota: examining differences in urine and tissue samples
por: Mansour, Bassel, et al.
Publicado: (2020)